The acquired assets generated net revenues of $55 million in 2011, up more than 20% from the year-ago period. Revenues were primarily generated in Russia (approximately 90%) and Commonwealth of ...
MISSISSAUGA, Ont. – Valeant Pharmaceuticals International is expanding its presence in Eastern Europe by acquiring Austrian generic drug company Gerot Lannach’s assets primarily in Russia for less ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results